Conflict of Interest
Richard J Harvey is a consultant with Medtronic, Stryker, Novartis,
Meda, and NeilMed pharmaceuticals. Research grant funding received from
Glaxo-Smith-Kline and Stallergenes. He has been on the speakers’ bureau
for Glaxo-Smith-Kline, Meda Pharmaceuticals and Seqirus. Janet Rimmer
has honoraria with Sanofi Aventis, Novartis, Mundipharma, BioCSL, and
Stallergenes. Larry H Kalish is on the speakers’ bureau at Mylan,
Sequiris and Care Pharmaceuticals. Raymond Sacks is a consultant for
Medtronic and is on the speaker’s bureau for Meda Pharmaceuticals. All
other authors have no financial disclosures or conflicts of interest.